Daily electronic self-monitoring of subjective and objective symptoms in bipolar disorder-the MONARCA trial protocol (MONitoring, treAtment and pRediCtion of bipolAr disorder episodes): A randomised controlled single-blind trial

BMJ Open

Volumn 3, Issue 7, 2013, Pages

  Faurholt Jepsen, Maria ^a   Vinberg, Maj ^a   Christensen, Ellen Margrethe ^a   Frost, Mads ^b   Bardram, Jakob ^b   Kessing, Lars Vedel ^a  

^a Rigshospitalet   (Denmark)

^b IT UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT; PLACEBO;

ADULT; ARTICLE; BIPOLAR DISORDER; CLINICAL PROTOCOL; COGNITION; COMPUTER INTERFACE; COMPUTER PROGRAM; CONTROLLED STUDY; DEPRESSION; DRUG BLOOD LEVEL; EMOTIONAL DISORDER; FEEDBACK SYSTEM; HUMAN; INTERNET; MAJOR CLINICAL STUDY; MANIA; MEDICATION COMPLIANCE; MOBILE PHONE; NURSE; ONLINE MONITORING; PATIENT COMPLIANCE; PREDICTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SELF MONITORING; SINGLE BLIND PROCEDURE; SOCIAL INTERACTION; STRESS;

EID: 84883437725     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-003353     Document Type: Article

References (51)

1. Pini S, de Queiroz V, Pagnin D, et al. Prevalence and burden of bipolar disorders in European countries. Eur Neuropsychopharmacol 2005;15: 425-34. (Pubitemid 40943546)
2. Sherazi R, McKeon P, McDonough M, et al. What's new? The clinical epidemiology of bipolar I disorder. Harv Rev Psychiatry 2006;14: 273-84. (Pubitemid 44949909)
3. Angst J, Sellaro R. Historical perspectives and natural history of bipolar disorder. Biol Psychiatry 2000;48: 445-57.
4. Kessing LV, Andersen PK, Mortensen PB, et al. Recurrence in affective disorder. I. Case register study. Br J Psychiatry 1998;172: 23-8. (Pubitemid 28122522)
5. Kessing LV, Hansen MG, Andersen PK, et al. The predictive effect of episodes on the risk of recurrence in depressive and bipolar disorders - a life-long perspective. Acta Psychiatr Scand 2004;109: 339-44. (Pubitemid 38491280)
6. Kessing LV, Hansen MG, Andersen PK. Course of illness in depressive and bipolar disorders. Naturalistic study, 1994-1999. Br J Psychiatry 2004;185: 372-7. (Pubitemid 39482072)
7. Torrent C, Martinez-Arán A, del Mar Bonnin C, et al. Long-term outcome of cognitive impairment in bipolar disorder. J Clin Psychiatry 2012;73:e899-905.
8. Goodwin GM, Geddes Jr. Latest maintenance data on lithium in bipolar disorder. Eur Neuropsychopharmacol 2003;13(Suppl 2): S51-5. (Pubitemid 37083233)
9. Vieta E, Pacchiarotti I, Valentí M, et al. A critical update on psychological interventions for bipolar disorders. Curr Psychiatry Rep 2009;11: 494-502.
10. Baldessarini RJ, Salvatore P, Khalsa H-MK, et al. Morbidity in 303 first-episode bipolar I disorder patients. Bipolar Disord 2010;12: 264-70.
11. Morriss RK, Faizal MA, Jones AP, et al. Interventions for helping people recognise early signs of recurrence in bipolar disorder. Cochrane Database Syst Rev 2007;(1):CD004854.
12. Berk M, Malhi GS, Hallam K, et al. Early intervention in bipolar disorders: clinical, biochemical and neuroimaging imperatives. J Affect Disord 2009;114: 1-13.
13. Vestergaard P, Schou M. Prospective studies on a lithium cohort. 1. General features. Acta Psychiatr Scand 1988;78: 421-6.
14. Hansen HV, Kessing LV. Adherence to antidepressant treatment. Expert Rev Neurother 2007;7: 57-62. (Pubitemid 46105296)
15. Kessing LV, Søndergård L, Kvist K, et al. Adherence to lithium in naturalistic settings: results from a nationwide pharmacoepidemiological study. Bipolar Disord 2007;9: 730-6. (Pubitemid 350042408)
16. Bonsall MB, Wallace-Hadrill SMA, Geddes JR, et al. Nonlinear time-series approaches in characterizing mood stability and mood instability in bipolar disorder. Proc Biol Sci 2012;279: 916-24.
17. Bopp JM, Miklowitz DJ, Goodwin GM, et al. The longitudinal course of bipolar disorder as revealed through weekly text messaging: a feasibility study. Bipolar Disord 2010;12: 327-34.
18. Ankers D, Jones SH. Objective assessment of circadian activity and sleep patterns in individuals at behavioural risk of hypomania. J Clin Psychol 2009;65: 1071-86.
19. Benazzi F. What is hypomania? Tetrachoric factor analysis and kernel estimation of DSM-IV hypomanic symptoms. J Clin Psychiatry 2009;70: 1514-21.
20. Kessing LV. The effect of comorbid alcoholism on recurrence in affective disorder: a case register study. J Affect Disord 1999;53: 49-55. (Pubitemid 29227352)
21. Renfordt E. Changes of speech activity in depressed patients under pharmacotherapy. Pharmacopsychiatry 1989;22(Suppl 1): 2-4. (Pubitemid 19071775)
22. Sobin C, Sackeim HA. Psychomotor symptoms of depression. Am J Psychiatry 1997;154: 4-17. (Pubitemid 27020186)
23. Frye MA, Helleman G, McElroy SL, et al. Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. Am J Psychiatry 2009;166: 164-72.
24. Dilsaver SC, Akiskal HS. 'Mixed hypomania' in children and adolescents: is it a pediatric bipolar phenotype with extreme diurnal variation between depression and hypomania? J Affect Disord 2009;116: 12-17.
25. Weinstock LM, Miller IW. Functional impairment as a predictor of short-term symptom course in bipolar I disorder. Bipolar Disord 2008;10: 437-42. (Pubitemid 351517377)
26. Kuhs H, Reschke D. Psychomotor activity in unipolar and bipolar depressive patients. Psychopathology 1992;25: 109-16.
27. Kupfer DJ, Weiss BL, Foster G, et al. Psychomotor activity in affective states. Arch Gen Psychiatry 1974;30: 765-8.
28. Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c869.
29. Boutron I, Moher D, Altman DG, et al. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 2008;148: 295-309. (Pubitemid 351665487)
30. Chan A-W, Tetzlaff JM, Altman DG, et al. SPIRIT 2013: new guidance for content of clinical trial protocols. Lancet 2013;381: 91-2.
31. Kessing LV, Hansen HV, Hvenegaard A, et al. Treatment in a specialised out-patient mood disorder clinic v. standard out-patient treatment in the early course of bipolar disorder: randomised clinical trial. Br J Psychiatry 2013;202: 212-19.
32. Wing JK, Babor T, Brugha T, et al. SCAN. Schedules for clinical assessment in neuropsychiatry. Arch Gen Psychiatry 1990;47: 589-93. (Pubitemid 20189971)
33. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6: 278-96.
34. Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978;133: 429-35. (Pubitemid 9006756)
35. Bardram J, Frost M, Szanto K, et al. The MONARCA self-assessment system: a persuasive personal monitoring system for bipolar patients. Proceeding IHI '12 Proceedings of the 2nd ACM SIGHIT; New York, NY: ACM, 2013: 21-30.
36. Rosa AR, Sánchez-Moreno J, Martínez-Aran A, et al. Validity and reliability of the functioning assessment short test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health 2007;3:5.
37. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983;24: 385-96.
38. Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment. The WHOQOL Group. Psychol Med 1998;28: 551-8.
39. Endler NS, Parker JD. Coping inventory for stressful ituations (CISS). Multi-health systems. Manual. 2nd edn. 1998.
40. Bech P, Olsen LR. [Discovering depression]. Ugeskr Laeg 2001;163: 1980-2.
41. Bech P, Rasmussen NA, Olsen LR, et al. The sensitivity and specificity of the major depression inventory, using the present state examination as the index of diagnostic validity. J Affect Disord 2001;66: 159-64. (Pubitemid 32907521)
42. Olsen LR, Jensen DV, Noerholm V, et al. The internal and external validity of the major depression inventory in measuring severity of depressive states. Psychol Med 2003;33: 351-6. (Pubitemid 36221467)
43. Altman EG, Hedeker D, Peterson JL, et al. The Altman Self-Rating Mania Scale. Biol Psychiatry 1997;42: 948-55. (Pubitemid 27486450)
44. Fava M, Iosifescu DV, Pedrelli P, et al. Reliability and validity of the Massachusetts general hospital cognitive and physical functioning questionnaire. Psychother Psychosom 2009;78: 91-7.
45. Kirschbaum C, Hellhammer DH. Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology 1994;19: 313-33. (Pubitemid 24150545)
46. Levine A, Zagoory-Sharon O, Feldman R, et al. Measuring cortisol in human psychobiological studies. Physiol Behav 2007;90: 43-53. (Pubitemid 44918006)
47. Cadet J, Poulsen H. Measurement of oxidatively generated base damage in cellular DNA and urine. Free Radic Biol Med 2010;48: 1457-9.
48. Weimann A, Broedbaek K, Henriksen T, et al. Assays for urinary biomarkers of oxidatively damaged nucleic acids. Free Radic Res 2012;46: 531-40.
49. Trajkovska V, Marcussen AB, Vinberg M, et al. Measurements of brain-derived neurotrophic factor: methodological aspects and demographical data. Brain Res Bull 2007;73: 143-9. (Pubitemid 46722657)
50. Guilera G, Pino O, Gómez-Benito J, et al. Clinical usefulness of the screen for cognitive impairment in psychiatry (SCIP-S) scale in patients with type I bipolar disorder. Health Qual Life Outcomes 2009;7:28.
51. Rojo E, Pino O, Guilera G, et al. Neurocognitive diagnosis and cut-off scores of the screen for cognitive impairment in psychiatry (SCIP-S). Schizophr Res 2010;116: 243-51.